GBG research at SABCS

We are happy to present our trials at the San Antonio Breast Cancer Symposium (SABCS) December 2023.

• “Exploring Circulating Leukocyte RNA Expression: Implications for Treatment Outcomes and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial”  - Poster Spotlight Discussion
• “Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA)” - Poster Presentation 
• “CDH1 mutations predict resistance to neoadjuvant taxane therapy” - Poster Presentation
• “Overall survival and disease recurrence rates in patients with invasive lobular breast cancer of the PenelopeB cohort” - Poster Presentation

Poster downloads will be availabe here after the conference.

• Visit the conference website.